TRUE Stock Overview
Treatment.Com International Inc. provides personalized health care information services in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Treatment.com AI Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.57 |
| 52 Week High | CA$1.11 |
| 52 Week Low | CA$0.35 |
| Beta | -0.45 |
| 11 Month Change | -16.18% |
| 3 Month Change | -26.92% |
| 1 Year Change | 0% |
| 33 Year Change | -95.62% |
| 5 Year Change | n/a |
| Change since IPO | -98.19% |
Recent News & Updates
Shareholder Returns
| TRUE | CA Healthcare Services | CA Market | |
|---|---|---|---|
| 7D | 1.8% | 4.1% | 2.2% |
| 1Y | 0% | 100.0% | 23.4% |
Return vs Industry: TRUE underperformed the Canadian Healthcare Services industry which returned 99.2% over the past year.
Return vs Market: TRUE underperformed the Canadian Market which returned 23.4% over the past year.
Price Volatility
| TRUE volatility | |
|---|---|
| TRUE Average Weekly Movement | 7.1% |
| Healthcare Services Industry Average Movement | 9.1% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.7% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: TRUE has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: TRUE's weekly volatility has decreased from 14% to 7% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Essam Hamza | www.treatment.com |
Treatment Com International Inc. provides personalized health care information services in Canada. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management.
Treatment.com AI Inc. Fundamentals Summary
| TRUE fundamental statistics | |
|---|---|
| Market cap | CA$27.92m |
| Earnings (TTM) | -CA$2.01m |
| Revenue (TTM) | CA$38.14k |
732.2x
P/S Ratio-13.9x
P/E RatioIs TRUE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TRUE income statement (TTM) | |
|---|---|
| Revenue | CA$38.14k |
| Cost of Revenue | CA$13.95k |
| Gross Profit | CA$24.19k |
| Other Expenses | CA$2.03m |
| Earnings | -CA$2.01m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.041 |
| Gross Margin | 63.43% |
| Net Profit Margin | -5,268.63% |
| Debt/Equity Ratio | -91.6% |
How did TRUE perform over the long term?
See historical performance and comparison